Is Iovance Biotherapeutics Inc (IOVA) Stock at the Top of the Biotechnology Industry?

Iovance Biotherapeutics Inc (IOVA) is around the top of the Biotechnology industry according to InvestorsObserver. IOVA received an overall rating of 64, which means that it scores higher than 64 percent of all stocks. Iovance Biotherapeutics Inc also achieved a score of 84 in the Biotechnology industry, putting it above 84 percent of Biotechnology stocks. Biotechnology is ranked 53 out of the 148 industries.

IOVA has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on IOVA!

See Full IOVA Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 64 would rank higher than 64 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Iovance Biotherapeutics Inc Stock Today?

Iovance Biotherapeutics Inc (IOVA) stock is trading at $5.48 as of 12:04 PM on Wednesday, Nov 22, a gain of $0.30, or 5.9% from the previous closing price of $5.17. The stock has traded between $5.24 and $5.51 so far today. Volume today is low. So far 2,076,718 shares have traded compared to average volume of 6,663,925 shares. Click Here to get the full Stock Report for Iovance Biotherapeutics Inc stock.